Back to Authors

Christensen, Kevin N

Mayo Clinic

Department of Dermatology, Mayo Clinic, Rochester, Minnesota.

Citations 2

Carbon dioxide laser treatment for Hailey–Hailey disease: a retrospective chart review with patient‐reported outcomes
Hochwalt, Phillip C., Christensen, Kevin, Cantwell, Sean , Hocker, Thomas L., Otley, Clark C. , Brewer, Jerry D., Arpey, Christopher J., Roenigk, Randall K., Baum, Christian L. , Christensen, Kevin N, Cantwell, Sean R.

International Journal of Dermatology | October 13, 2015 | Volume: 54 | Issue: 11 | Pages: 1309-1314

10.1111/ijd.12991 Get It

AbstractBackgroundHailey–Hailey disease (HHD) is an autosomal dominant genodermatosis that leads to skin breakdown and blister formation, usually in intertriginous areas. Laser ablation is a known surgical treatment for HHD.ObjectivesWe report outcomes in a series of patients with HHD treated with carbon dioxide (CO2) laser ablation.MethodsA retrospective chart review of data for 13 patients who underwent CO2 laser ablation for HHD was conducted. Questionnaires assessing effectiveness, pain, healing time, recurrence, new disease, complications, additional ablation, improvement in quality of life (QoL), and overall satisfaction were completed by all patients.ResultsAll patients had been recalcitrant to previous treatments prior to CO2 laser ablation. Anatomic sites treated and anesthesia techniques for the procedure varied. The mean ± standard deviation (SD) score for the effectiveness of CO2 laser ablation for HHD was 9.3 ± 0.9 (maximum: 10). All patients reported improved QoL. No patient had recurring disease within the treatment field. Five patients underwent additional CO2 laser treatments at new sites. One patient reported postoperative infection. No other complications were identified. The mean ± SD score for overall satisfaction with CO2 laser ablation was 8.9 ± 1.1.ConclusionsTreatment with CO2 laser ablation is very effective and can lead to prolonged or permanent remission in most HHD patients. Patients are highly satisfied with the results and report a substantial improvement in QoL.
Pediatric Lichen Planopilaris: Clinicopathologic Study of Four New Cases and a Review of the Literature
Christensen, Kevin, Lehman, Julia S. , Tollefson, Megha M. , Christensen, Kevin N, Lehman, Julia S

Pediatric Dermatology | June 10, 2015 | Volume: 32 | Issue: 5 | Pages: 621-627

10.1111/pde.12624 Get It

Abstract Lichen planopilaris ( LPP ) is a rare form of cicatricial alopecia that has occasionally been reported in children. Because of the limited number of patients reported, little information is available about demographic characteristics, clinical presentation, or treatment options for these patients. A retrospective chart review of LPP cases in patients under 18 years of age from 1976 to 2013 was performed to further define clinicopathologic features of pediatric LPP . Four pediatric LPP patients ages 13 to 16 years were identified (three male, one female). One patient had scalp pruritus and one had other cutaneous findings of lichen planus ( LP ). Perifollicular scale and scarring were the most common physical examination findings, although changes mimicking those of alopecia areata were observed. Three patients were treated with topical or intralesional steroids. One patient was treated with minocycline. Histopathologic findings included perifollicular interface and perifollicular fibrosis in all cases. There was focal interfollicular interface in two cases and mild dermal mucin in one case. LPP is exceedingly rare in children. It may be misdiagnosed as alopecia areata in children because of the lack of symptoms and other features of LP . There should be a high index of suspicion for LPP in children with alopecia that is unresponsive to standard treatment or who have findings that are atypical for more common childhood alopecias.